Abnormality of N30 somatosensory evoked potentials in Parkinson’s disease: a multidisciplinary approach

PURPOSE OF THE STUDY Assess the N30 component of median nerve somatosensory evoked potentials (SEPs) in patients with Parkinson's disease (PD) and correlate its parameters with the severity of the disease, general cognitive ability and regional cerebral blood flow (rCBF). PATIENTS AND METHODS Twenty-three non-demented, non-depressed PD patients (at stage II and III of the disease) and 23 age- and education-matched normal controls were enrolled in the study. SEPs were elicited by median nerve stimulation. PD patients' cognitive ability was assessed by means of: 1) Raven's Colored Progressive Matrices (RCPM); 2) the Test of Non-Verbal Intelligence (TONI-2); and 3) the Wisconsin Card Sorting Test (WCST). The patients' rCBF was evaluated by HMPAO SPECT. RESULTS There was no difference between SEP N30 latency in PD patients and controls (P > 0.05). The P20-N30 peak-to-peak amplitude was lower in PD patients bilaterally (P < 0.05), and the amplitude of N30-P40 was lower on the right side only (P < 0.05). A significant increase in the amplitude ratio P14-N20/P20-N30 was observed in PD patients (P < 0.05). The correlation of these findings with the clinical parameters of the disease, and notably motor signs, was not significant. Of the three neuropsychological tests only the RCPM showed a positive relation to right P20-N30 amplitude. Regression analysis between SEP parameters and rCBF showed a correlation of N30 amplitude with blood flow in parietal cortical areas, but not in frontal regions.

[1]  R Ferri,et al.  Scalp topographic mapping of middle-latency somatosensory evoked potentials in normal aging and dementia , 1996, Neurophysiologie Clinique/Clinical Neurophysiology.

[2]  R. Passingham,et al.  Functional specialization of the supplementary motor area in monkeys and humans. , 1996, Advances in neurology.

[3]  P. Goldman-Rakic,et al.  Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  D. Goodin,et al.  The frontal N30 component of the median‐derived SEP in patients with predominantly unilateral Parkinson's disease , 1995, Neurology.

[5]  W W Sutherling,et al.  Functional anatomy of human hand sensorimotor cortex from spatiotemporal analysis of electrocorticography. , 1991, Electroencephalography and clinical neurophysiology.

[6]  A Urbano,et al.  Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. , 1989, Electroencephalography and clinical neurophysiology.

[7]  G. Bernardi,et al.  SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status , 1997, European journal of neurology.

[8]  Dystonia and the supplementary sensorimotor area. , 1996, Advances in neurology.

[9]  F. Mauguière,et al.  Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. , 1993, Electroencephalography and clinical neurophysiology.

[10]  Stephen J. Jones,et al.  Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings. , 1991, Brain : a journal of neurology.

[11]  V. Drory,et al.  N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease , 1998, Acta neurologica Scandinavica.

[12]  P M Rossini,et al.  Brain excitability and long latency muscular arm responses: non-invasive evaluation in healthy and parkinsonian subjects. , 1991, Electroencephalography and clinical neurophysiology.

[13]  H. Teräväinen,et al.  Pre‐ and postcentral cortical somatosensory evoked potentials in hemiparkinsonism , 1993, Movement disorders : official journal of the Movement Disorder Society.

[14]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[15]  M Wiesendanger,et al.  Recent developments in studies of the supplementary motor area of primates. , 1986, Reviews of physiology, biochemistry and pharmacology.

[16]  J. Fuh,et al.  Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. , 1992, Nuclear medicine communications.

[17]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[18]  J. Noth,et al.  Absence of frontal somatosensory evoked potentials in Huntington's disease. , 1993, Brain : a journal of neurology.

[19]  A J Lees,et al.  HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[20]  P M Rossini,et al.  Somatosensory evoked potentials during the ideation and execution of individual finger movements , 1996, Muscle & nerve.

[21]  Allan H. Ropper,et al.  Evoked potentials in clinical medicine (second of two parts). , 1982 .

[22]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[23]  M Hallett,et al.  The N30 component of somatosensory evoked potentials in patients with dystonia. , 1992, Electroencephalography and clinical neurophysiology.

[24]  P. Rossini,et al.  Parkinson's disease and somatosensory evoked potentials , 1993, Neurology.

[25]  M. Onofrj,et al.  The abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations , 1995, Movement disorders : official journal of the Movement Disorder Society.

[26]  C C Wood,et al.  Human cortical potentials evoked by stimulation of the median nerve. II. Cytoarchitectonic areas generating long-latency activity. , 1989, Journal of neurophysiology.

[27]  G. Cheron,et al.  Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave. , 1994, Electroencephalography and clinical neurophysiology.

[28]  P M Rossini,et al.  Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism. , 1995, Electroencephalography and clinical neurophysiology.